| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.2M | +160.4% | +16.3% |
| Cost of Revenue | $2.7M | +139.4% | +12.7% |
| Gross Profit | $1.6M | +206.7% | +23.2% |
| R&D Expense | $33K | +6.5% | -36.5% |
| SG&A Expense | $844K | +25.4% | +19.7% |
| Operating Income | -$260K | +70.0% | +48.0% |
| Net Income | -$290K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $2.5M | +351.7% | +49.7% |
| Inventory | $1.1M | -41.7% | +39.5% |
| Current Assets | $5.7M | +74.3% | +83.5% |
| Total Assets | $6.8M | +80.4% | +80.1% |
| Current Liabilities | $4.5M | +175.2% | +104.9% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.2M | — | — |
| Capital Expenditures | $42K | — | — |
| Investing Cash Flow | -$42K | — | — |
| Financing Cash Flow | $3.9M | — | — |
| Free Cash Flow | -$2.2M | — | — |
| +67.0% |
| +43.5% |
| EPS (Basic) | -$0.02 | +66.7% | +33.3% |
| EPS (Diluted) | -$0.02 | +66.7% | +33.3% |
| $596K |
| +238.6% |
| +142.3% |
| Total Liabilities | $4.9M | +183.4% | +105.7% |
| Stockholders' Equity | $1.9M | -6.2% | +36.9% |